API SUPPLIERS

API Suppliers

43

US DMFs Filed

21

CEP/COS Certifications

JDMFs Filed

Other Certificates

Other Suppliers

API REF. PRICE (USD / KG)

283

API Market Place

12

INTERMEDIATES

7

DOSSIERS // FDF

USA (Orange Book)

48

Europe

110

Canada

5

Australia

0

South Africa

14

Uploaded Dossiers

19

GLOBAL SALES (USD Million)

U.S. Medicaid

270.00

Annual Reports

0

FDF Market Place

12

EXCIPIENTS

143

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

2

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

5

REF STANDARD

EDQM

3

USP

5

JP

0

Other Listed Suppliers

14

SERVICES

1

Full Screen View

Sarfez Pharmaceuticals

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Novo Integrated Sciences’ Subsidiary, Clinical Consultants International, Signs Consulting Agreement with Pharmaceutical Research & Development Compan...

Details:

Sarfez’s FDA-approved, once-a-day novel formulation of loop diuretic torsemide, SOAANZ®, provides a new treatment option for patients suffering from heart failure who experience persistent edema or swelling in the lower limbs and/or abdomen.

Lead Product(s): Torsemide

Therapeutic Area: Cardiology/Vascular Diseases Product Name: Soaanz

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Novo Integrated Sciences

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Agreement November 30, 2022

ASK
US

Upload
your Marketing & Sales content

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Find Drugs in Development News & Deals for Prestwick3_001030

Prestwick3_001030

Prestwick3_001030

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

43 API Suppliers

21 USDMF

18 CEP/COS

1 JDMF

9 EU WC

3 KDMF

11 NDC API

25 Listed Suppliers

DEVELOPMENTS

1 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

INTERMEDIATES

7 Suppliers

DOSSIERs // Finished Dosage Formulations

196 Dossiers

48 FDA Orange Book

110 Europe

5 Canada

14 South Africa

19 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

25 Kerry

15 Roquette

14 BASF

12 Microlex e.U

10 Sigachi Industries

8 Gangwal Healthcare

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

7 Boai NKY Pharmaceuticals Ltd

6 Gangwal Chemicals

6 DFE Pharma

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

4 SPI Pharma

4 Pharmatrans-Sanaq

3 Prachin Chemical

3 Vasa Pharmachem

3 Ingredion Pharma Solutions

3 Ulanqab Kema New Material

2 Nanjing Well Pharmaceutical

1 DKSH

1 Ideal Cures Pvt Ltd

1 BioSpectra

1 Seppic

1 Clariant

1 Alcedo Pharmachem

1 Shanghai Welltone Material Technology Co., Ltd

EXCIPIENTS BY APPLICATIONS

61 Fillers, Diluents & Binders

32 Direct Compression

31 Disintegrants & Superdisintegrants

20 Granulation

16 Thickeners and Stabilizers

13 Co-Processed Excipients

13 Lubricants & Glidants

10 Solubilizers

8 Controlled & Modified Release

8 Chewable & Orodispersible Aids

5 Parenteral

5 Taste Masking

5 Coating Systems & Additives

3 Film Formers & Plasticizers

3 Topical

2 API Stability Enhancers

2 Rheology Modifiers

2 Emulsifying Agents

TABLET;ORAL - 100MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 20MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons